Monthly Archives: August 2016

Affordable Anchored Dentures Now Available for Colorado Springs Residents

August 29, 2016 – – ReNew 1-Day Dentures is now offering the Southern Colorado area the opportunity to get the ReNew anchored denture. Revolutionary, advanced smile technology has now arrived in Colorado Springs for people suffering with missing or failing teeth or those tired of shifting dentures.

ReNew Anchored Dentures are dentures supported by dental implants. The ReNew Anchored Denture provides people in need the ability to get a stable, anchored set of beautiful new teeth at a price they can afford.

ReNew was developed for people who wanted dental implant treatment but were unable to proceed with treatment due to the price. ReNew implant-supported, anchored dentures are significantly less expensive while still retaining the quality and functionality of dental implants.

One key technological advancement for ReNew patients is ReNew’s exclusive use of the Good Fit Anchored Dentures™. Good Fit® is the newest, most innovative component which allows ReNew’s doctors to give patients a beautiful, new anchored smile in just one day.

Dr. Erich Zimmermann, chief clinical director for ReNew says, “ReNew has partnered up with Good Fit®, and we are the exclusive provider of the Good Fit® denture. With Good Fit®, we’re able to provide an excellent result in one day where it normally takes 4 or 5 weeks to make a set of teeth. Now we’re able to do it quicker and more efficiently and give an awesome product to the patient.”

ReNew patients are excited to have this new option, like Rick from Pueblo. “I felt that the ReNew denture would be a better experience for me because of the implant. It’s been an amazing change,” says Rick.

James from Colorado Springs says his ReNew Anchored Dentures feel just like natural teeth. “With the ReNew anchored denture, the experience is completely different than what I experienced before with my old dentures. Before if I took a bite out of something like a hamburger or a sandwich, my dentures tend to clam shell and they pop loose in the back and they shift around… it became painful. With the ReNew anchored denture the experience is entirely different – I don’t worry about that at all. I can eat whatever I want without fear.”

Sally from North Springs says she was worried about the price, but ReNew made it affordable for her. “I’m a widow and I’m a single person so if I can afford it, I think everybody can afford it. And it just gives you so much pride. You know you feel better about your smile, about everything. You don’t have to worry anymore.”

Those who are interested in learning more about ReNew 1-Day Dentures or want to take advantage of their free consultation which includes a free 3-D Cat scan, call ReNew today at 844-417-7111, or visit the website at http://renew1daydentures.com.

###

Contact ReNew 1-Day Dentures:

844-417-7111
info@renewcorp.com
7070 S. Tucson Way
Centennial, Colorado 80112

ReleaseID: 60012071

New Website Offers Advice On Healthy Relationships

August 29, 2016 – – Vanity Hills is a newly launched website that offers insights into healthy relationships of all types. The site’s bloggers encourage readers to lead healthy mental and physical lives to ensure that their relationships do not suffer.

“We’ve all had some sort of relationship issues at some point,” says a spokesperson for the new site. “We’ve worried that our marriages were doomed, wondered about the best ways of conceiving, or generally just needed advice from someone who’s been there.”

That, the spokesperson says, is what Vanity Hills is all about. The site publishes blog posts regularly that pertain to a variety of relationship issues from dating and marriage to having and raising children, and fitting it all into a healthy coupledom.

The site offers information on a variety of relationship topics including fertility issues. One post outlines a personal story from one of the bloggers and her path to gaining a large family. Other posts are designed to provide marriage tips and other advice or facts that will help couples to answer various questions about their relationships.

In addition to the tips, advice, and personal stories, the site also offers insights or “did you know” sequences that are designed to bring a bit of fun to readers. “They’re just little facts that we’ve found and wanted to share,” says the spokesperson. “We think they’re interested and a bit whimsical and we hope our readers enjoy them as well.”

The spokesperson states that the quips will be updated regularly as well, giving readers something new and interesting with virtually every visit. The site plans to update content on a regular basis, offering insights into various topics of interest to those in committed relationships and those who are still searching for their significant other.

The spokesperson explains that their main goal is to educate readers on being happy with themselves, which will in turn, make them happier in their relationships. She states that inner happiness is key to making any commitment in a relationship work. Those who are interested in learning more about the new site or in reading their recent posts can visit them online.

###

Contact Chemekx:

Karla
07841867380
mekx@hotmail.co.uk
65-66 woodrow
London
Se18 5dh

ReleaseID: 60011987

Texas Company Launches Bed Bug Control Services

August 29, 2016 – – Charlette’s Web Pest Control has announced a new type of service for customers in Tomball, Spring, and The Woodlands, Texas. The pest control company recently stated that they are now offering bed bug control services in addition to the other services. The company has noted that a study performed by Bugs Without Borders in 2015 states that bed bugs are the most difficult pests to control.

A spokesperson for Charlette’s Web Pest Control agrees. She says, “They’re more difficult to contain and exterminate than ants or even roaches. Unfortunately, many consumers don’t realize this and they spend sometimes thousands of dollars on DIY treatments that ultimately fail.”

The company states that depending on the scope of the infestation, it could take several treatments to completely control it. Recent news stories show that the bed bug population has grown to alarming heights all over the world. Their resurgence over the past 50 years has many consumers concerned.

“It’s good to be concerned,” says Charlette. “People need to learn ways of preventing the spread of bed bugs and they need to know how to handle them if and when they do bring them home.”

The company states that professional pest control services are nearly always needed to effectively rid the home of these unwanted pests. Charlette states that a focus on prevention can go a long way in helping to rid the world of these pests. She says that even if they are not gone forever, if consumers learn how to effectively prevent their spread, they can help to minimize the population.

“It’s all about education,” says the company spokesperson. Charlette’s Web Pest Control offers bed bug removal services and they state that they will educate their customers as much as possible about the bugs, their habits and hiding places, and how to best prevent spreading them. The company states that while the bugs can be difficult to eradicate, they can be effectively removed and often the first step in ridding a home of them is education.

More about the methods that the company uses for bed bug control and their other pest control services can be seen on their official website.

###

Contact Charlette’s Web Pest Control:

Charlette
281-841-0093
chutton1@gmail.com

ReleaseID: 60011972

Charlette’s Web Announces Growth Of Pest Control Services In Tomball, Texas

August 29, 2016 – – Charlette’s Web Pest Control is a Texas based company offering more than mere pest control services in Spring and Tomball. The company recently announced that due to their award-winning customer service, contact from consumers looking for pest control services has increased drastically.

“We always strive to put our customers first,” says a spokesperson for the company. “Our growth, particularly in the Tomball area, shows that we are making the right choice.”

The company states that this is the time of year in Texas when many bugs can begin to get out of hand. From mosquitos and ants to more difficult to remove bed bugs, Charlette’s Web Pest Control offers a wide range of services that are designed to assist consumers with all of their pest control needs.

“We just want to offer our customers the level of service that we would expect from a pest control company,” says the company spokesperson. “Our aim is now and will always be to eradicate pests and give consumers a reason to come back to us for services in the future.”

As part of their winning customer service, the company offers numerous services for pest control Tomball residents can take advantage of. They state that they can eradicate virtually any pest or rodent, and they urge consumers to contact them at the first hint of a pest infestation to avoid the frustrations of living with unwanted guests.

The company states that they use methods and products that have their customers’ best interests at heart. They state that the first step is a consultation, where the situation is thoroughly assessed and then a solution is planned. The company says that while many pest control companies will merely use the same methods for every customer, Charlette’s Web Pest Controlstrives to provide one on one service for each customer, ensuring that each individual need is met.

The company says that it’s this individualized treatment that has customers virtually knocking down their door to schedule a consultation. Those interested in learning more about pest control Spring residents can use, can visit the company on their official website to get a look at the services they provide and the specific areas that they serve.

###

Contact Charlette’s Web Pest Control:

Charlette
281-841-0093
chutton1@gmail.com

ReleaseID: 60011973

MCG Introduces Open Paid Time Off Policy


August 29, 2016 – The Dallas-based accounting firm Montgomery Coscia Greilich LLP (MCG) has formally adopted an Open Paid Time Off (PTO) policy for full-time exempt employees. Under the Open PTO policy, employees are allowed to take as much time off as they need. This differs greatly from the Firm’s outgoing, traditional PTO policy that dictates how many days off an employee is allowed to take. Additionally, the Firm increased its paid maternity leave to 12 weeks. The Firm feels that these changes more accurately reflect their culture of autonomy, flexibility, and trust. The new policies will go into effect on January 1, 2017.

“At MCG, we believe that our employees work hard and should have opportunities to enjoy time away from work to help balance their lives, relax, and creatively recharge. In addition, we are committed to creating a culture of personal responsibility and mutual trust. We want our vacation and time off policy to reflect both of these elements. Our employees will be empowered to take responsibility for balancing their client and personal commitments in a manner that works best for them, their clients and their teammates,” commented partner Scott McCrillis.

Daniel Ryan, MCG employee, commented, “The new Open PTO policy formally puts in writing the Firm’s trust in its employees and commitment to promoting work life balance. The policy is both encouraging and empowering as an employee, in that it gives me an opportunity to exercise my own personal responsibility and judgement, allowing me an element of control in my schedule.”

Earlier this month, MCG was recognized as one of Dallas’ “Best Places to Work” by the Dallas Business Journal. MCG is known for being an innovative, entrepreneurial, and autonomous workplace, which is reflective in its progressive people policies. In addition to the new Open PTO and maternity leave policy, MCG has been an early adopter of the current trend “dress for the day”. The Firm has never had a dress code policy and entrusts partners and employees to use their judgment when working in the office, meeting with clients or attending other meetings that call for business casual or business dress. Otherwise, you can find MCG team members in jeans most days.

Matt Coscia, co-managing partner, stated further, “We’ve informally let people take time as they needed since the inception of our firm. It just made sense to adopt a formal policy that makes it easier for team members to plan and take the time they need to be the best they can be while at work.”

About Montgomery Coscia Greilich LLP
MCG began in 2003 and currently has over 325 professionals including 29 partners. The Firm is ranked as the 6th largest accounting firm in the Dallas/Fort Worth Metroplex by the Dallas Business Journal, and provides taxation, assurance, and consulting services to a wide range of clients. We are a member of the Alliott Group, a worldwide alliance of independent accounting, law, and consulting firms with more than 170 member firms in some 70 countries. MCG is consistently recognized by Accounting Today and INSIDE Public Accounting as one of the top 100 accounting firms in the country. We were named as the Fastest-Growing Accounting Firm in the Country for 2015 by the INSIDE Public Accounting.

GET IN TOUCH
Sharla Gunn
Montgomery Coscia Greilich

http://www.mcggroup.com

Release ID: 248957

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Embraer S.A. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Lundin Law PC (the “Firm”) announces a class action lawsuit has been filed against Embraer S.A. (“Embraer” or the “Company”) (NYSE: ERJ) concerning possible violations of federal securities laws between April 16, 2012 and July 28, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the October 7, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The Complaint alleges that during the Class Period, the Company made false and misleading statements and/or failed to disclose material facts, specifically: that it paid bribes to Dominican Republic officials to secure contracts for aircraft sales; that Embraer’s President and CEO Frederico Curado had knowledge of the bribe; that the fallout from this misconduct would cost Embraer hundreds of millions of dollars; and as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. In June 2016, the Company stated that its CEO Frederico Curado would be stepping down. On July 29, 2016, Embraer announced a loss of $99.4 million for the quarter after setting aside $200 million in connection with a U.S. Foreign Corrupt Practices Act probe that it was negotiating with the U.S. Department of Justice since May 2015. The Company also reduced 2016 guidance for its executive jet business. When this information was disclosed to the public, Embraer shares dropped in value.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 444501

DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses in Excess of $25,000 to Contact the Firm

IRVINE, CA / ACCESSWIRE / August 29, 2016 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit has been filed against Lipocine Inc. (“Lipocine” or the “Company”) (NASDAQ: LPCN). Investors, who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm by the August 30,
2016 lead plaintiff motion deadline.

If you purchased Lipocine shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, the Company made false and/or misleading statements and/or failed to disclose that: Lipocine’s filing of its New Drug Application to the U.S. Food and Drug Administration for LPCN 1021 (the Company’s lead product candidate) contained deficiencies; and as a result, Lipocine’s statements about its business and operations were false and misleading and/or lacked a reasonable basis. When this information was disclosed to the public, shares of Lipocine declined in value, causing investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 444500

Global Fibromyalgia Pipeline Landscape and Therapeutics Development Market H2 2016

RnRMarketResearch adds Fibromyalgia Pipeline Market Research to its database.

Pune, India – August 29, 2016 /MarketersMedia/ —

Fibromyalgia Pipeline Market Companies Involved in Therapeutics Development are Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., SWITCH Biotech LLC, Theravance Biopharma, Inc., Tonix Pharmaceuticals Holding Corp. and Zynerba Pharmaceuticals, Inc.

The report provides comprehensive information on the therapeutics under development for Fibromyalgia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Fibromyalgia and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data
.
Scope

• The report provides a snapshot of the global therapeutic landscape of Fibromyalgia
• The report reviews pipeline therapeutics for Fibromyalgia by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Fibromyalgia therapeutics and enlists all their major and minor projects
• The report assesses Fibromyalgia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Fibromyalgia

Purchase a copy of this research report which is spread across 80 pages with TOC at http://www.rnrmarketresearch.com/contacts/purchase?rname=674856

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Fibromyalgia
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Fibromyalgia pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research

Source: http://marketersmedia.com/global-fibromyalgia-pipeline-landscape-and-therapeutics-development-market-h2-2016/129997

Release ID: 129997

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Orbital ATK, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Lundin Law PC (the “Firm”) announces a class action lawsuit has been filed against Orbital ATK, Inc. (“Orbital” or the “Company”) (NYSE: OA) concerning possible violations of federal securities laws between June 1, 2015 and August 9, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the October 11, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that during the Class Period, Orbital made materially false and misleading statements, and/or failed to disclose: that Orbital lacked effective control over financial reporting; that the Company failed to record an anticipated loss on a $2.3 billion long-term contract with the U.S. Army after the loss became evident in 2015, as required by generally accepted accounting principles; and that as a result of the above, Orbital’s public statements were materially false and misleading at all relevant times.

On August 10, 2016, the Company announced that it would miss its SEC Form 10-Q filing deadline for the most recent quarter and that several previous financial statements are no longer reliable due to misstatements relating to the above-mentioned contract with the U.S. army. When this news was disclosed to the public, shares of Orbital decreased in value, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 444498

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Concordia International Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Lundin Law PC (the “Firm”) announces a class action lawsuit was filed against Concordia International Corp. (“Concordia” or the “Company”) (NASDAQ: CXRX) concerning possible violations of federal securities laws between November 12, 2015 and August 12, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the October 14, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that during the Class Period, the Company made false and misleading statements and/or failed to disclose: that Concordia was facing increased market competition against its drug Donnatal and other products; that the Company’s financial results would suffer and thus it would be forced to suspend its dividend; and that as a result of the above, Concordia’s statements about its business, operations and prospects were false and misleading and/or lacked a reasonable basis.

On August 12, 2016, Concordia announced that it would lower its 2016 guidance due to unexpected competition and current foreign exchange rates. The Company also announced that CFO Adrian de Saldanha was leaving, and that the Board unanimously agreed to suspend the Company’s quarterly dividend. When this news was disclosed to the public, shares of Concordia dropped in value, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 444497